Skip to main content
Top
Published in: World Journal of Surgery 3/2016

01-03-2016 | Original Scientific Report

Surgical Treatment of NEN of Small Bowel: A Retrospective Analysis

Authors: F. M. Watzka, C. Fottner, M. Miederer, M. M. Weber, A. Schad, H. Lang, T. J. Musholt

Published in: World Journal of Surgery | Issue 3/2016

Login to get access

Abstract

Background

Neuroendocrine Neoplasms of the small intestine have been noticed more frequently over the past 35 years. They constitute about 25 % of all NENs and 29 % of all tumors of the small intestine. Due to the predominantly indolent nature and overall good prognosis, the benefit of surgical treatment is still debated.

Methods

In a retrospective study, data of 83 surgically treated patients with neuroendocrine neoplasms of the small intestine, 48 males and 35 females with a median age of 62 years (range 25–86 years) were analyzed. Patient data were documented in the MaDoc database for neuroendocrine tumors of the University Medical Center of Mainz. IBM SPSS Statistics 20 was used for statistical analysis. Kaplan–Meier survival curves and Log-Rank tests, censoring patients at the time of last follow-up, were used to compare the overall survival depending on potential prognostic factors (stage, grade, surgical treatment).

Results

At the time of diagnoses, the most common clinical symptoms were abdominal pain (n = 31, 37.3 %), bowel obstruction (n = 11, 13.3 %), bowel perforation and peritonitis (n = 3, 3.6 %), gastrointestinal bleeding (n = 9, 10.8 %), weight loss (n = 11, 13.3 %), and carcinoid syndrome (n = 27, 32.5 %). 65 patients (78.3 %) had lymph node metastasis and in 58 patients (69.9 %) distant metastasis were present. Segmental bowel resection (44) was the most common surgical procedure, followed by right hemi-colectomy (32) and explorative laparotomy (7). In most patients (78.9 %), lymphadenectomy (systematic/selective) was performed. The 5-year survival of patients who underwent a systematic or a selective lymphadenectomy differed significantly (82.2 vs. 40.0 %). The overall 3-, 5-, and 10-year survival rates were 88.2, 80.3, and 71.0 %, respectively.

Conclusion

Mesenteric lymph node metastases are almost invariably present and have significant impact on patients’ prognosis. Systematic lymphadenectomy prevents complications and improves the survival. Early surgical treatment should be the goal in order to prevent complications.
Literature
1.
go back to reference Bilimoria KY, Bentrem DJ, Wayne JD et al (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63–71CrossRefPubMed Bilimoria KY, Bentrem DJ, Wayne JD et al (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63–71CrossRefPubMed
2.
go back to reference Akerstrom G, Hellman P (2007) Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 21:87–109CrossRefPubMed Akerstrom G, Hellman P (2007) Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 21:87–109CrossRefPubMed
3.
go back to reference Rindi G, Kloppel G, Couvelard A et al (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451:757–762CrossRefPubMed Rindi G, Kloppel G, Couvelard A et al (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451:757–762CrossRefPubMed
4.
go back to reference Pape UF, Jann H, Muller-Nordhorn J et al (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256–265CrossRefPubMed Pape UF, Jann H, Muller-Nordhorn J et al (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256–265CrossRefPubMed
5.
go back to reference Jann H, Roll S, Couvelard A et al (2011) Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome. Cancer 117:3332–3341CrossRefPubMed Jann H, Roll S, Couvelard A et al (2011) Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome. Cancer 117:3332–3341CrossRefPubMed
7.
go back to reference Basson MD, Ahlman H, Wangberg B et al (1993) Biology and management of the midgut carcinoid. Am J Surg 165:288–297CrossRefPubMed Basson MD, Ahlman H, Wangberg B et al (1993) Biology and management of the midgut carcinoid. Am J Surg 165:288–297CrossRefPubMed
8.
go back to reference Ahlman H, Wangberg B, Jansson S et al (1991) Management of disseminated midgut carcinoid tumours. Digestion 49:78–96CrossRefPubMed Ahlman H, Wangberg B, Jansson S et al (1991) Management of disseminated midgut carcinoid tumours. Digestion 49:78–96CrossRefPubMed
9.
go back to reference Touzios JG, Kiely JM, Pitt SC et al (2005) Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241:776–783 discussion 783-775 PubMedCentralCrossRefPubMed Touzios JG, Kiely JM, Pitt SC et al (2005) Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241:776–783 discussion 783-775 PubMedCentralCrossRefPubMed
10.
go back to reference Que FG, Sarmiento JM, Nagorney DM (2006) Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. Adv Exp Med Biol 574:43–56CrossRefPubMed Que FG, Sarmiento JM, Nagorney DM (2006) Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. Adv Exp Med Biol 574:43–56CrossRefPubMed
11.
go back to reference Ahmed A, Turner G, King B et al (2009) Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer 16:885–894CrossRefPubMed Ahmed A, Turner G, King B et al (2009) Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer 16:885–894CrossRefPubMed
12.
go back to reference Akerstrom G, Hellman P, Hessman O et al (2005) Management of midgut carcinoids. J Surg Oncol 89:161–169CrossRefPubMed Akerstrom G, Hellman P, Hessman O et al (2005) Management of midgut carcinoids. J Surg Oncol 89:161–169CrossRefPubMed
13.
go back to reference Landry CS, Brock G, Scoggins CR et al (2008) A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg 196:896–903 discussion 903 CrossRefPubMed Landry CS, Brock G, Scoggins CR et al (2008) A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg 196:896–903 discussion 903 CrossRefPubMed
14.
go back to reference Musholt TJ (2011) Extent of resection for neuroendocrine tumors of the small intestine. Chirurg 82:591–597CrossRefPubMed Musholt TJ (2011) Extent of resection for neuroendocrine tumors of the small intestine. Chirurg 82:591–597CrossRefPubMed
15.
go back to reference Scherubl H, Jensen RT, Cadiot G et al (2010) Neuroendocrine tumors of the small bowels are on the rise: early aspects and management. World J Gastrointest Endosc 2:325–334PubMedCentralCrossRefPubMed Scherubl H, Jensen RT, Cadiot G et al (2010) Neuroendocrine tumors of the small bowels are on the rise: early aspects and management. World J Gastrointest Endosc 2:325–334PubMedCentralCrossRefPubMed
17.
Metadata
Title
Surgical Treatment of NEN of Small Bowel: A Retrospective Analysis
Authors
F. M. Watzka
C. Fottner
M. Miederer
M. M. Weber
A. Schad
H. Lang
T. J. Musholt
Publication date
01-03-2016
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 3/2016
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3432-2

Other articles of this Issue 3/2016

World Journal of Surgery 3/2016 Go to the issue